MAIA
MAIA
AMEX · Biotechnology

Maia Biotechnology Inc

$1.97
+0.06 (+3.14%)
As of Feb 8, 2:15 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,016.2% upside
Low Target $18.66
Average Target $21.99
High Target $31.61
Current Price $1.97
Current
$1.97
Target
$21.99
$18.66 $21.99 avg $31.61
Scenario Analysis
Bear Case
$18.66
847.2%
Low target
Base Case
$21.99
+1,016.2%
Avg target
Bull Case
$31.61
+1,504.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$29.33
-93.3% from high
52-Week Low
$12.16
+-83.8% from low
Target vs 52W High
$21.99
-25.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%